1. Home
  2. EVO vs LGIH Comparison

EVO vs LGIH Comparison

Compare EVO & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.73

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Logo LGI Homes Inc.

LGIH

LGI Homes Inc.

HOLD

Current Price

$41.20

Market Cap

1.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
LGIH
Founded
1993
2003
Country
Germany
United States
Employees
4553
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Homebuilding
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
934.1M
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
EVO
LGIH
Price
$2.73
$41.20
Analyst Decision
Strong Buy
Hold
Analyst Count
1
5
Target Price
$7.00
$75.90
AVG Volume (30 Days)
95.9K
422.6K
Earning Date
04-08-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.09
Revenue
N/A
$1,705,504,000.00
Revenue This Year
$1.37
$2.32
Revenue Next Year
$10.05
$17.94
P/E Ratio
N/A
$450.67
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$33.55
52 Week High
$4.80
$69.42

Technical Indicators

Market Signals
Indicator
EVO
LGIH
Relative Strength Index (RSI) 41.07 41.02
Support Level $2.32 $35.87
Resistance Level $3.78 $41.50
Average True Range (ATR) 0.09 2.15
MACD -0.06 -0.77
Stochastic Oscillator 19.16 10.21

Price Performance

Historical Comparison
EVO
LGIH

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About LGIH LGI Homes Inc.

LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.

Share on Social Networks: